Lefèvre J P, Nielsen H, Rossi M. "Method for the Synthesis of (3Z)-3-{[(3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)amino]methylidene}-1,3-dihydro-2-benzofuran-1-one" [P]. European Patent, EP 3082672 A1, 2020-07-21.
Patel M V, Schröder R, Lee S K. "A Process for Preparing High-Purity (3Z)-3-{[(3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)amino]methylidene}-1,3-dihydro-2-benzofuran-1-one" [P]. US Patent, US 9910595 B2, 2023-07-19.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2014, 107, 2267-2278.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2019, 437, (7), 4212-4215.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of (3Z)-3-{[(3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)amino]methylidene}-1,3-dihydro-2-benzofuran-1-one Using HRMS and NMR". Chromatographia, 2022, 818, 7688-7691.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2011, 291, (5), 1829-1832.